申请人:Consonni Alessandra
公开号:US20070197603A1
公开(公告)日:2007-08-23
New ligands for the ORL-1 receptor are described, useful for modulating the activity of said receptors in a patient in need thereof, and for preventing and treating illnesses dependent on the stimulation of this receptor. The new compounds conform to structural formula (I),
wherein Q is a moiety of formula:
and R, R
0
, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
are further defined in the description.
本文描述了ORL-1受体的新配体,可用于调节患者中该受体的活性,并用于预防和治疗依赖于该受体刺激的疾病。新化合物符合结构式(I),其中Q是以下式子的一个基团:而R,R0,R1,R2,R3,R4,R5,R6在描述中进一步定义。